John, Swen-Malte

Profile

Full Name
John, Swen-Malte
 
Variants
John, S
John, S-M
John, SM
John, Swen
John, Swen M
John, Swen Malte
John, Swen-Malte
John, Swen M.
John, Swen M
 
FIS NetID
 
ORCID
 
Country
Germany
 
Lädt ... 2 0 20 0 false
 
Lädt ... 3 0 20 0 false
 

Publications


Aktive Filter:
Person:  Nienhaus, A.

1-9 von 9

ErscheinungsdatumTitelAutor(en)
12008Prevalence of hand eczemas in the old-age care - First results of the KRISTA-studySkudlik, C. ; Dulon, M.; John, S. M. ; Nienhaus, A.
22009Validity and responsiveness of the Osnabruck Hand Eczema Severity Index (OHSI): a methodological studyDulon, M.; Skudlik, C. ; Nuebling, M.; John, S. M. ; Nienhaus, A.
32022Recommendation: long-term therapy of occupational hand eczema with alitretinoin within therapies of the employer's liability insurance associationSymanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; John, S. M. 
42022Indication and Reimbursement of Costs for Biologics in professional Association Treatment by using the example of Dupilumab: A Basis for DiscussionSymanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St; Skudlik, C. ; John, S. M. 
52022Recommendation: Indication and cost coverage for biologics within therapies of the employer's liability insurance association by the example of Dupilumab: a basis for discussionSymanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St; Skudlik, C. ; John, S. M. 
62022Novel systemic medications-especially for treatment of atopic dermatitis-within therapies of the employer?s liability insur- ance association-a basis for discussionSymanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, S.; Skudlik, C. ; John, S. M. 
72022Recommendation: Indication and cost coverage for biologics within therapies of the employer's liability insurance association by the example of Dupilumab: A basis for discussion [Indikation und Kostenübernahme von Biologika im berufsgenossenschaftlichen Heilverfahren am Beispiel von Dupilumab: Eine Diskussionsgrundlage]Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St.; Skudlik, C. ; John, S.M. 
82023Implementation and evaluation of an e-learning training concept for the imple- mentation of the German occupational dis- eases legal changes regarding the occupa- tional disease number 5101Symanzik, C.; Altenburg, C.; Awe, S.; Palsherm, K.; Marx, M.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, S.; Skudlik, C. ; John, S. M. 
92023Semipermeable gloves in the prevention of occupational skin diseases: Potentials and limitationsHeichel, T.; Sonsmann, F. K.; John, S. M. ; Nienhaus, A.; Nordheider, K.; Wilke, A.; Brans, R.